本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Unicycive Therapeutics, Inc.

0.5500
-0.0721-11.59%
盤後0.56010.0101+1.84%18:56 EDT
成交量:180.03萬
成交額:103.25萬
市值:6,583.78萬
市盈率:-0.97
高:0.6379
開:0.6300
低:0.5450
收:0.6221
資料載入中...
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/31

重要事件披露

8-K - Current report
2022/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/20

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/29

重要事件披露

8-K - Current report
2021/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

重要事件披露

8-K - Current report
2021/09/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/16

重要事件披露

8-K - Current report
2021/07/12

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/12

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/08

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/08

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/07

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/06

SEC問詢函

CORRESP [Cover] - Correspondence